萬方發展(000638.SZ)擬轉讓信通網易55.3%的股權 置出醫療信息化相關業務
格隆匯2月13日丨萬方發展(000638.SZ)公佈,公司於2020年2月12日與易剛曉簽署《股權轉讓意向書》,公司擬將持有的控股子公司成都信通網易醫療科技發展有限公司(“信通網易”)55.30%股權進行轉讓。在完成對信通網易的審計評估後,公司將與易剛曉或其指定的第三方簽訂正式《股權轉讓協議》。
鑑於受國內經濟下行及疫情的影響,公司管理層正在探討公司未來發展和新業務戰略轉型及落地工作,此次公司將置出醫療信息化相關業務以滿足新業務的拓展。
此次股權轉讓將導致公司合併財務報表範圍發生變更,信通網易將不再是公司的控股子公司。截至目前,公司貿易收入穩定,並即將開展不良資產運營管理及其他投資業務。此次股權轉讓構成重大資產重組,股權轉讓方將嚴格按照深交所《股票上市規則》和公司《重大投資管理辦法》的相關規定履行所需的審議程序。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.